Monoclonal antibodies to RNA-modifications (MOONSHOT)

Ended Definitive Contract Awarded Last action

Contract number
75N91018C00031
Awardee
Awarding agency
Obligated
$299,999

Award facts

Opportunity
  • PHS201801 Solicitation number
Contract value 100% obligated
$299,999.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
Total Small Business
Competition
Full and Open Competition after exclusion of sources · 8 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Pottstown, PA 19464, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Change Order P00002 $0
Other Administrative Action P00001 · Project title: monoclonal antibodies to RNA-modifications $0
Original award $299,999

About this award

The National Cancer Institute awarded a $299,999 definitive contract to Abzyme Therapeutics LLC for monoclonal antibodies to RNA-modifications (MOONSHOT) on September 17, 2018, under a total small business set-aside.

The project addresses development of monoclonal antibodies targeting RNA-modifications. Place of performance is Pottstown, Pennsylvania. The contract carries a firm fixed price and a ceiling value of $299,999, with an ultimate completion date of December 16, 2019.

Quick answers

Who was awarded contract 75N91018C00031?

75N91018C00031 was awarded to Abzyme Therapeutics LLC by National Cancer Institute (National Institutes of Health) on September 17, 2018.

How much is contract 75N91018C00031 worth?

The government has obligated $299,999 on 75N91018C00031.

Was contract 75N91018C00031 competed?

The extent of competition for 75N91018C00031 was full and open competition after exclusion of sources. The government received 8 offers. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award